Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS Influence on Endothelial Function in Hypertension
NCT04371757Unknown
- Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of doxazosin in systemic arterial hypertension (HTN) (3 arms), sponsored by Instituto de Cardiologia do Rio Grande do Sul. Primary endpoint: Flow Mediated Dilation. Status: unknown.
02
Drugs
doxazosin
03
Conditions
systemic arterial hypertension (HTN)
Beyond the preview
Go deeper on NCT04371757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371757.